SirVir Ltd., an Aposense subsidiary in the field of respiratory viral infections announce the fulfillment of a $14M milestone investment
SirVir Ltd., an Aposense subsidiary in the field of respiratory viral infections announce the fulfillment of a $14M milestone investment from Access Industries. Prior to this transaction SirVir reached its scientific milestone when generating safety and efficacy data against the SARS CoV2 on a non-human primates model
Read More